Rare diseases
Investigational molecules
Locations
12407 North Mopac Expressway Suite 250 # 390, 78758-2491, United States
Rein Therapeutics Inc. is focused on idiopathic pulmonary fibrosis, with clinical research centered on the management of progressive lung scarring and its impact on respiratory function.
The sponsor’s current trial activity reflects interest in treatment options for patients living with established pulmonary fibrosis and related respiratory decline.
Rein Therapeutics Inc. runs clinical trials in conditions such as Idiopathic pulmonary fibrosis, among others.
Clinical trials run by this sponsor – those enrolling participants first.
GermanyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
